EUVIMEDObjevte EUVIMED
Crossref

Sunscreens prescribed to patients with skin of color and/or with melasma: A survey of 221 dermatologists and dermatology residents in Spain

Daniel Morgado-Carrasco iD, Jesús Delgado, Ludmila Prudkin-Silva iD, Júlia Santamaria, Jaime Piquero-Casals

Photodermatology, Photoimmunology & Photomedicine · 2024

DOI: 10.1111/phpp.12996 ↗

At a glance

Journal article in Photodermatology, Photoimmunology & Photomedicine, 2024. Written by Daniel Morgado-Carrasco and 4 co-authors. Institution: Dermatology Department, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain. Major MEDLINE topics: Sunscreening Agents, Melanosis, Dermatologists, Skin Pigmentation. Cited 5 times so far (Crossref); 21 references.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Dark‐skinned individuals (DSI) present high rates of melasma and post‐inflammatory hyperpigmentation. The use of sunscreens with mineral filters is essential for prevention and treatment. Our objective was to determine the preferences of dermatologists and dermatology residents in the prescription of sunscreens for DSI.

Methods

An anonymous survey of attendees at an online photoprotection event held on March 31, 2022, in Spain.

Results

The survey was answered by 66.6% (221/332) of the attendees: 159 dermatologists (71.9%) and 62 dermatology residents (28.1%). Respondents reported recommending the use of sunscreen to a median of 80% of DSI [interquartile range (IQR), 50–90]. Physicians reported prescribing tinted sunscreens to a median percentage of 60% (IQR, 25–90) of DSI with acne; and to a median percentage of 90% (IQR, 58–99) of DSI with melasma. The most prescribed photoprotectors to DSI with melasma were organic broad‐spectrum sunscreens with antioxidants: 102/220 (46.4%) and mineral broad‐spectrum sunscreens (with iron oxides): 45/220 (20.4%). In DSI with melasma or other pigmentary disorders, the most preferred features of sunscreens were as follows: sun protection factor ≥ 30: 217/221 (98.2%), UVA protection: 214/221 (96.8%), color for camouflage: 150/220 (68.2%) and mineral filters such as titanium dioxide and zinc oxide: 151/220 (68.6%) or iron oxides: 131/220 (59.5%).

Limitations

Online survey, potential inclusion bias.

Conclusions

Respondents reported to prescribe sunscreens to the majority of DSI, and tinted sunscreens for the majority of DSI with pigmentary disorders. However, the most frequently recommended sunscreens for DSI were organic broad‐spectrum sunscreens with antioxidants.

Subjects

MeSH terms (MEDLINE)

Sunscreening AgentsMelanosisDermatologistsSkin PigmentationHumansSpainFemaleSurveys and QuestionnairesMaleInternship and ResidencyAdultPractice Patterns, Physicians'Middle Aged

Author keywords

dark skinmelasmaphotoprotectionpost‐inflammatory hyperpigmentationskin of colorsunscreen

Substances

Sunscreening Agents

Authors and institutions

  • Dermatology Department, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.
  • Innovation and Development, ISDIN, Barcelona, Spain.
  • Dermik Clínica Dermatológica Multidisciplinar, Barcelona, Spain.

ORCID profiles: Daniel Morgado-Carrasco, Ludmila Prudkin-Silva

Cite

APA

Morgado-Carrasco, D., Delgado, J., Prudkin-Silva, L., Santamaria, J., & Piquero-Casals, J. (2024). Sunscreens prescribed to patients with skin of color and/or with melasma: A survey of 221 dermatologists and dermatology residents in Spain. Photodermatology, Photoimmunology & Photomedicine. https://doi.org/10.1111/phpp.12996

Vancouver

Morgado-Carrasco D, Delgado J, Prudkin-Silva L, Santamaria J, Piquero-Casals J. Sunscreens prescribed to patients with skin of color and/or with melasma: A survey of 221 dermatologists and dermatology residents in Spain. Photodermatology, Photoimmunology & Photomedicine. 2024. doi:10.1111/phpp.12996

BibTeX
@article{MorgadoCarrasco2024,
  author = {Morgado-Carrasco, Daniel and Delgado, Jesús and Prudkin-Silva, Ludmila and Santamaria, Júlia and Piquero-Casals, Jaime},
  title = {Sunscreens prescribed to patients with skin of color and/or with melasma: A survey of 221 dermatologists and dermatology residents in Spain},
  journal = {Photodermatology, Photoimmunology & Photomedicine},
  year = {2024},
  doi = {10.1111/phpp.12996}
}
Start for free →